Health Care
(E60)
IRS Verified
DX Registered
990 on File
SOCIETY OF ST VINCENT DE PAUL CHARITABLE PHARMACY OF NORTH TEXAS
Financial strength (30%)
63/100
Reliability (20%)
50/100
Effectiveness (25%)
71/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
The mission of the SVdP Pharmacy is to share God’s love by providing free prescription medications to those unable to afford them, because everyone deserves the dignity of access to health-sustaining prescription medications.
Financial Overview — FY 2024
$30.7M
Total Revenue
$31.6M
Total Expenses
$4.7M
Net Assets
11
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
99.2%
Fundraising Efficiency
N/A
Operating Reserve
1.77x
Liability-to-Asset
1.9%
Revenue Diversification
99.9%
Compared with Peers
FY 2024
Compared with 2,013 similar organizations
(United States, Health Care, $10M–$100M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
99.2% | 84.6% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
0.3% | 14.6% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.5% | 0.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
1.8 mo | 6.8 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
1.9% | 35.3% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
99.9% | 92.5% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
2.7% | 7.3% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
4.2% | 7.7% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-2.8% | 1.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $30.7M | $31.6M | $4.7M | 99.2% | 11 |
| 2023 | $29.9M | $30.3M | $5.5M | 99.5% | 10 |
| 2022 | $28.4M | $24.4M | $5.9M | 99.8% | 8 |
| 2021 | $4.5M | $3.3M | N/A | — | 5 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.